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ANALYSIS OF THE CLEAR PLAQUE PHENOTYPE OF THE BACTERIOPHAGE 
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Chandrika Kunapuli                        December 2010                                            60 pages 
Directed by: Rodney King, Claire Rinehart and Sigrid Jacobshagen 
Department of Biology                                                           Western Kentucky University 
     The growth of bacteriophage HK75 is inhibited by specific mutations in the zinc 
binding domain of the host RNA polymerase beta prime subunit.  It shares this rare 
property with bacteriophage HK022 and other phages that use RNA mediated 
antitermination to promote early gene expression.  Recent genomic analysis of HK75 and 
HK022 has confirmed the relatedness of these two phages and place HK75 in the 
lambdoid family of bacteriophages.  Lambdoid phages are temperate and can adopt a 
lytic or lysogenic lifestyle upon infection of a suitable host.   However, HK75 only forms 
clear plaques and thus appears to be defective in its ability to form lysogens.  Based on 
published analyses of other lambdoid phages, a clear plaque phenotype is commonly due 
to a mutation in one of 5 phage genes: cI, cII, cIII, int, xis or the phage repressor DNA 
binding sites.  To determine which mutation is responsible for the clear plaque phenotype 
of HK75, we cloned the cI and cIII genes and assayed their activities.  The HK75 cI gene 
clone prevented super-infection by HK75.  This result demonstrated repressor 
functionality and thus the clear plaque phenotype cannot be due to a mutation in the 
HK75 cI gene.  Several amino acid differences were noted between the HK022 and 
HK75 CIII proteins.  To determine if the clear plaque phenotype was due to mutations in 
viii 
 
the HK75 cIII gene, we cloned it into an expression vector.  Only under conditions of cIII 
gene overexpression were lysogens of HK75 recovered.  The phage CIII protein normally 
protects CII from proteolysis.  Stabilization of CII by mutations in specific host proteases 
has been shown to suppress a clear plaque phenotype caused by mutations in the cIII 
gene.  When HK75 was plated on a protease deficient strain of E. coli, turbid plaques 
were formed and lysogens were recovered.  These results support the idea that the clear 
plaque phenotype of HK75 is due to a defect in the expression of the phage cIII gene. 
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INTRODUCTION 
 Bacteriophage 
     Bacteriophages or phages are viruses that infect bacteria and are obligate intracellular 
parasites. The word “phage” is derived from a Greek word „‟phagein‟‟ which means to 
eat or devour bacteria [28]. Bacteriophages are ubiquitous and can be easily found in soil, 
water and food.  Phages are microscopic and measure about 20-200nm in length [28].  
They are specific for their bacterial host and can even differentiate between host strains.  
This feature of phages has been used clinically in a method called phage typing [29].  The 
specificity of phages for their hosts is due to specific interactions with receptors on the 
outer surface of the bacteria, which are typically composed of carbohydrates, lipids or 
proteins [29]. 
     The structural features of lambdoid bacteriophages include a head or capsid and a               
tail (Figure1). The head is typically icosahedral and contains the nucleic acid acting as a 
protective covering for the phage genome and prevents its degradation by nucleases [31]. 
The tail is attached to the phage head and is a hollow tube. During the infection process, 
the nucleic acid passes through the attached tail into the bacteria. The nucleic acid of a 
phage can either be DNA or RNA but not both [16]. The genetic material of temperate 
phages is usually double stranded DNA [5].
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Figure 1. Schematic representation of the structure of a Lambdoid bacteriophage with the 
head, collar, tail and tail fibres. The icosahedral head contains the phage genome. 
Attached to the head is a long cylindrical tail. The phage tail fibers recognize the bacterial 
receptors and mediate attachment to the host. The genome is then injected into the 
bacterial cell and the infection process begins.  
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     There are two general types of bacteriophages: temperate phages and lytic phages.  
Both types of phages utilize the host‟s machinery to replicate the viral DNA, produce 
new phage particles and release the newly formed virions by lysing the host cell (Figure 
2).  Cell lysis is promoted by a phage encoded enzyme that has lysozyme like activity. 
The enzyme degrades the peptidoglycan layer of the bacterial cell wall, whose normal 
function is to maintain the structural integrity of the cell. Temperate phages on the other 
hand show another mode of existence called lysogeny.  In the lysogenic state, the phage 
chromosome is integrated into the bacterial chromosome [7].  The resulting cell is called 
a lysogen and the phage that has integrated into the host chromosome is called a 
prophage (Figure 3).  
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Figure 2. The steps involved in the lytic cycle of a bacteriophage infection.  Phage 
infection follows a series of defined steps: Attachment, penetration (injection of the 
genetic material) / uncoating, replication, maturation, assembly and release [23]. 
Attachment of a bacteriophage to its host cell is highly specific.  Once attached, the 
phage genome is injected into the host cell. The phage uses the transcription and 
translation machinery of the host to produce mature phage particles. Assembly of the 
phage particles is followed by final release of the daughter virions by the lysis of the host 
cell [23]. 
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Figure 3.  The lysogenic cycle of a temperate bacteriophage.  Once the phage genome is 
inserted into the host, it is circularized and integrated into the host chromosome at 
specific sites called an attB site.  The integrated phage is called a prophage and the host 
cell that carries the prophage is called a lysogen.  Many prophages can be induced to 
excise itself out of the host genome and recircularize to follow the lytic pathway when 
exposed to UV radiation. 
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History of Bacteriophages 
     In 1896, Ernest Hankin, a British bacteriologist was the first to observe that there was 
antimicrobial activity in the waters of Ganges and Jumna rivers in India against V. 
cholera.  He suggested that an unidentified substance that was heat labile and could pass 
through porcelain filters was responsible for preventing the spread of cholera epidemics 
[28].  Frederick Twort (1915) and Felix d‟Herelle (1917) later recognized that viruses can 
infect bacteria.  The name “bacteriophage” was proposed by d‟Herelle and his wife after 
he isolated „anti-Shiga‟ microbe from dysentery patients [28]   
     Felix d‟Herelle‟s rediscovery of bacteriophages occurred while he was studying an 
outbreak of dysentery among French soldiers.  He made bacterial free filtrates in order to 
isolate phage particles devoid of bacterial contamination from these patients and 
incubated the filtrate with strains of Shigella isolated from the same patients.  A portion 
of the mixtures were inoculated into animals as part of his studies to develop anti 
dysenteric vaccine.  He took those mixtures and plated them onto the agar plates.  Small, 
clear zones were observed on the agar cultures which he initially called as „‟taches’’ 
[meaning spots] and finally „‟plaques’’ [patch or large spot] (Figure 4) [28]. 
 
 
 
 
 
 
 
9 
 
 
 
 
 
 
 
Figure 4. Bacteriophage plaques on a lawn of bacterial cells.  The plaques or clear zones 
represent the areas of lysis of the bacterial host by the bacteriophages [Picture taken by 
Natalie Schieber]. 
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     Antibiotic resistant bacteria are one of the main challenges in medicine today.  
Bacteriophage therapy involves the use of bacteriophages to combat drug resistant 
bacteria [11].  Felix d‟Herelle was the first to use phages therapeutically.  He 
administered anti-dysenteric phage to a 12 year old boy with severe dysentery and the 
boy recovered within days of this treatment. Three other patients with bacterial dysentery 
were treated by administering a single dose of phage. They all recovered within 24 hours 
of treatment.   In 1921 Richard Bruynoghe and Joseph Maisin used bacteriophages to 
treat Staphylococcal skin diseases [28]. The lesions were opened surgically and the 
bacteriophages were injected into and around the lesions. Regression of the infections 
occurred within 24-48 hours of treatment [28].  These results suggested that phage can be 
used in the treatment of bacterial diseases. 
Bacteriophage Lambda   
     Bacteriophage lambda has been a paradigm for understanding gene expression. This 
phage was discovered accidentally by Esther Lederberg during her studies on E. coli.  
She found that when bacterial cells were irradiated with ultraviolet light, they stopped 
growing and eventually lysed releasing phage particles [12].  Lambda is a temperate 
phage and consists of a head and a tail with tail fibers [19].  The head bears the linear 
double stranded DNA which is 48,514 base pairs with unique 12bp single stranded ends 
called cos or cohesive sites [13].  It also consists of an immunity system that prevents 
superinfection of its E.coli lysogens [9]. 
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Figure 5. Schematic representation of the λ early transcriptional units.  The early genes 
are organized into two operons driven by a rightward pR and a leftward pL promoter. The 
rightward transcription expresses genes cro, cII, O, P and Q [20].  O and P carryout the 
lytic DNA replication and Q is the late gene regulator. The cro gene product is important 
for establishing the lytic cycle by binding to the operator OR.  As a result RNA 
polymerase cannot bind to PRM and this prevents CI repressor synthesis. pR‟ is the late 
lytic promoter.  pI (promoter for integrase), pRM (promoter for repressor maintenance) 
and pRE (promoter for repressor establishment) are required for lysogeny. Leftward 
transcription expresses the N, cIII, gam, red, xis and int genes. The N protein promotes 
transcription antitermination at tL1 and tR1 which are the left and right operon 
terminators.  The protein CIII acts as a lysogenic regulator by protecting CII protein from 
protease degradation.  When the CII protein is stabilized it can activate transcription of 
the cI gene from pRE promoter to establish lysogeny. att promotes the attachment of the 
phage to the host cell. Int carries out site specific recombination whereas Xis support the 
excision reaction [20].   
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Immunity Region 
     The immunity region of lambdoid phages consists of a short segment of phage 
chromosome that includes the cI, cII, cIII, N and the cro genes (Figure 6).  The product of 
the cI gene, λ repressor, is the only protein required for maintaining immunity.  It binds 
to two DNA binding sites called operators, OR and OL [27].  Repressor binding to these 
sites prevents the early phage gene transcription. The proteins CII and CIII function in 
the establishment of lysogeny [17].  CII acts as a transcriptional activator of cI gene 
transcription [20]. 
 
 
Figure 6. Illustration depicting the immunity region of the λ phage genome.  The 
immunity region includes cIII, N , cI, cro and cII .  Immunity is the property,  wherein the 
repressor produced by one phage bind to the operator regions of the incoming phage 
preventing its superinfection.  
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Antitermination 
     Antitermination is a mechanism used by some phages to promote full expression of 
phage genes located downstream of transcription terminators.  In lambda, anti-
termination is mediated by two different phage encoded proteins N and Q.  The N 
antiterminator protein modifies the RNA polymerase as it passes through the terminators 
[15].  The recognition sites of N are called nut (N utilization).  A copy of a nut site occurs 
in each of the major early operons:  nutL and nutR respectively. Recognition of the nut 
sites by N leads to a persistent antitermination complex formation when a number of 
E.coli host proteins such as nusA, nusB and nusC modify RNA polymerase to a 
terminator resistant form.  The Q antiterminator protein promotes late gene expression by 
recognizing the qut sites (Q utilization sites) present in the late phage promoter [13]. 
The phage CI protein is the central protein in maintaining lysogeny and is encoded by cI 
gene.  It is a 236 amino protein that folds into two equal sized domains.  The active form 
of the repressor is a dimer that is formed through contacts in the carboxy terminal 
domains of two repressor monomers [21].  In λ lysogens, the CI protein binds to the left 
and right operators, OL and OR and blocks the expression of most phage genes. The 
affinity of the repressor for the operators is OR1>OR2>OR3.  Binding of the repressor to 
the operators prevents transcription from PL and PR promoters.  However, binding also 
activates transcription from the PRM promoter that is used for maintaining CI synthesis in 
lysogen [21].  The repressor dimers usually occupy OR2 thereby preventing the 
transcription of cro from PR.  There is cooperation between the repressor dimers bound at 
the operator sites. The binding of repressor at OR2 is facilitated by the repressor bound at 
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the OR1, whereas the binding of the repressor to OR3 is independent.  When repressor 
binds to OR3 it prevents transcription from PRM.  When the levels of CI become low, then 
CI would leave OR3 first and thus PRM would be reactivated before OR2 becomes free.  
When DNA damage occurs due to UV light exposure, the RecA protein stimulates the 
self cleavage of the λ repressor [10].  The inactivated repressor falls off of the operator 
sites and allows RNA polymerase to transcribe the early phage genes [22].  
Protein CII is a tetramer made up of two equivalent dimers. Each monomer consists of a 
helix-turn-helix DNA binding motif.  Synthesis of CII originates from the PR promoter 
for a short time before it is repressed by Cro or CI proteins.  CII is a transcriptional 
activator and play a major role in lysis-lysogeny decision by promoting transcription 
from three promoters PRE, PI and PAQ which are all required for the lysogenic pathway 
[20]. 
      The CIII protein is a 54 residue long peptide that promotes the transcription of cI 
gene indirectly by stabilizing the CII transcriptional activator [21].  It controls CII 
degradation by acting as an inhibitor for the host HflB protease [17].  The cIII gene is 
transcribed from the PL promoter. Its expression is controlled by CI, CRO, N and by the 
host RNaseIII protein [20].  The synthesis of CIII is inhibited by CI and CRO binding to 
the OL.  CIII protein expression is stimulated by N that acts at nut sites (nutL) and by 
RNaseIII that helps in the translation of CIII by acting as an RNA chaperone [1]. 
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Figure 7. Role of CII and CIII in lytic- lysogeny decision.  The CII protein is degraded 
by host protease HflB/FtsH.  When CII is degraded, the phage enters the lytic cycle.  The 
CIII protein acts as an antiprotease and protect CII from degradation.  When CII is 
stabilized, it acts as a transcription activator of two genes cI and int required for the 
establishment of  lysogeny. 
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Bacteriophage HK022 
     Bacteriophage HK022 is a temperate coliphage. It was isolated from barnyard effluent 
in Hong Kong by Drs.Tarlochan and Elvera Dhillon [31]. HK022 can form lysogens and 
they express a protein called Nun. Nun protein of these lysogens excludes Lambda from 
growing by binding to its nut sites [25]. It is the first phage to show RNA mediated 
antitermination.  Antitermination in HK022 is promoted by cis-acting RNA molecules 
called Put [15]. (Put stands for polymerase utilization since RNA polymerase is the only 
protein required for this process to occur). The nascent transcripts encoded by the putL 
and putR sites supress termination at downstream transcription terminators by binding to 
the transcription elongation complex of the phage HK022 [26]. PUT sequences form two 
stem-loops separated by a single unpaired nucleotide (Figure 8).  The Put RNA interacts 
with the zinc binding domain of the β‟ subunit of the RNAP [3]. The interaction 
transforms RNA polymerase into a termination resistant form [15].  
 
Figure 8. The structures of the HK022 PUTL and PUTR RNAs.  The put RNA promote 
antitermination. These put transcripts form two stem-loops. Both the internal loops and 
stems are important for activity. Mutations that prevent the base pair formation in the 
stems reduce antitermination function [30]. 
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Bacteriophage HK75: 
     Bacteriophage HK75 is a lambdoid phage that was isolated in Hong Kong by Dhillon 
in 1970 (Figure 9) [31].  HK75 is homoimmune with HK022 and it shares a high degree 
of DNA sequence homology with HK022.  Despite these similarities, bacteriophage 
HK75 cannot form lysogens when grown on a lawn of host cells.  The clear plaque 
phenotype could be due to a mutation in either the cI, cII or cIII genes [13].  
Alternatively, a mutation in the operators could also cause a clear plaque phenotype.   
Phages with such mutations are said to be virulent since they are insensitive to the 
presence of repressor and can even grow on a lysogenic cell [12]. 
 
 
 
Figure 9. TEM micrograph of bacteriophage HK75 stained with uranyl acetate.  The 
diameter of the head is approximately 56 nm and the tail length is approximately 154 nm. 
The scale bar is 100nm [Picture taken by Ali Wright]. 
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Experimental goals 
     The goal of this research project was to identify the mutation(s) responsible for the 
clear plaque phenotype of bacteriophage HK75.  The activities of genes known to play a 
role in the establishment of the lysogeny were investigated. 
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MATERIALS AND METHODS 
1. Chemicals and enzymes: 
 Chemicals:  X-gal and IPTG were purchased from Gold Biotechnologies. NaCl, phenol, 
Ampicillin and Tetracycline were purchased from Fisher.  LA PCR kit ver.2 (Cat. No. 
28104) was obtained from Takara.  Sigma-spin post reaction clean up kit (for purifying 
DNA sequencing reactions) (Cat. No. S5059-70EA) was obtained from Sigma Aldrich. 
The Millipore purification kit (Cat No.UFC510096) for the purification of plasmid DNA 
and PCR products was obtained from Amicon Ultra.  Plasmid prep kit (Cat No. 27104) 
and the QIAquick gel extraction kit (Cat.No.28704) were purchased from Qiagen.  DNA 
ladders and the agarose gel loading dye were purchased from Fisher. BigDye Terminator 
v3.1 cycle sequencing kit (Cat.No. 63202) was purchased from Applied Biosystems. 
 Enzymes: T4 DNA ligase, HindIII (NEB cat.no. R0104S, 20 U/µL), EcoR1 (NEB 
Cat.No. R0101S, 20 U/ µL) for cloning were obtained from NEB.  
2. Media and antibiotics:  
 Media : TB media ( 1% tryptone and 0.5% Nacl) and Luria-Bertani (LB) medium  ( 1% 
tryptone, 0.5 % yeast extract and 0.5% NaCl) , SOC (2% tryptone, 0.5% yeast extract, 
0.05% NaCl, 250 mM KCl, TB top agar (1% tryptone , 0.5% NaCl and 0.75% agar) were 
routinely used for the growth  of bacteria, phages and the strains carrying the plasmids. 
Antibiotics: Antibiotic stocks were prepared in the lab with appropriate concentrations 
which were filter sterilized and stored at -20 °C.  Antibiotics were used at the following 
concentrations: Ampicillin ( 25 µg/ml and 50 µg/ml), Tetracycline (15 µg/ml), 
kanamycin (20 µg/ml).
20 
 
 
 
3. Bacterial strains, plasmids and phage stocks 
The bacterial strains, plasmids and phage stocks used throughout this project are listed in 
Table 1, 2 and 3. Primers required for cloning, for confirming recombinants and 
sequencing were listed in Tables 4, 5 and 6.  Cultures of bacteria were grown in 5ml TB 
overnight at 37 °C.  The cells were harvested by centrifuging for 10 minutes at a speed of 
4,400 rpm in an eppendorf Centrifuge 5702 R. The pelleted cells were stored by 
resuspending in 2.5ml 10mM MgSO4   Strains containing plasmids used for cloning and 
recombineering were grown in TB media with appropriate antibiotics 
Table 1. Bacteria 
RK 898 MG1655 E. coli wild type K12 strain 
XL-1 endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 
F'[ ::Tn10 proAB+ lacIq _(lacZ)M15] hsdR17(rK- 
mK+)  
RK1219 AR3599 (HflB), a protease deficient strain Gift 
from Dr. Teru Ogura (Institute of Molecular 
Embryology and Genetics, Kumamoto University) 
and Dr. Don Court. 
RK1157A 
 
MC1000+ HK639 prophage with plasmid pRK1006 
recombineered with PCR products amplified from 
RK1142 (XL-1 carrying plasmid pRK729 with 
kanamycin gene) 
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Table 2. Plasmids 
pUC18 Multicopy plasmid of E.coli with 
ampicillin resistance gene and with α 
complement of lacZ gene [14]. 
1132A pUC 19 with transposon R6KAN-2 
(epicenter) in strain RK898 (MG1655) 
pBAD18 Expression vector with pBR322 origin of 
replication, AmpR marker and the pBAD 
promoter [24]. 
RK765 Strain XL-1 with pUC18 plasmid. 
RK 768 A Strain XL-1 transformed with pBAD18 
plasmid. 
 
 
Table 3. Phages 
HK75 Bacteriophage discovered in Hong Kong [31]. Uses 
unique RNA-based mechanism to promote transcription 
antitermination (R. King unpublished) 
HK022 A lambdoid bacteriophage discovered in Hong Kong 
sewers [31]. Uses unique RNA-based mechanism to 
promote transcription antitermination [22,30] 
W30 Clear plaque mutant of bacteriophage Lambda 
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Table 4. Primers required for cloning the HK75 cI and cIII genes  
RK578 5’GCATGAATTCAGGAGAActtatggttcaaca
gaaagag 3’ 
Forward primer for HK75 cI 
gene with a Shine-Dalgarno 
sequence for cloning of HK75 
cI gene. The EcoRI site is 
underlined. 
RK579 5’ GCATGAATTCcttatggttcaacagaaagag 3’ 
 
 
Forward primer for HK75 cI 
gene without a Shine dalgarno 
for cloning HK75 cI gene. The 
EcoRI site is underlined. 
RK580 5’ GCATAAGCTTctttaaggaaatttatttttatcc3’ 
 
Reverse primer for cloning 
HK75 cI gene. The HindIII 
site is underlined. 
RK581 5’GCATGAATTC gtataaataaggagcacacc 3’ Forward primer for cloning 
HK75 cIII gene. The EcoR1 
site is underlined. 
RK582 5’ GCATAAGCTTgaagcatctggtgattgatgg 3’ 
 
Reverse primer for cloning 
HK75 cIII gene. The HindIII 
site is underlined. 
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Table 5. Primers for confirming the recombinants. 
 
RK600 
5’GAGTGAATACACGGAGCAATGTCGC
TCGTAACTAAACAGGAGCCGACTTG 
GTGTCTCAAAATCTCTGATG 3’ 
Forward primer to amplify the 
KAN gene from plasmid 1132. 
 
 
RK601 
5’GGCTATTACTGCTTTGTTCTGTGCA
GCACGAAGCATCTGGTGATTGATGGA
CAACCAATTAACCAATTCTG 3‟ 
 Reverse primer to amplify the 
KAN gene from plasmid 1132. 
 
RK583 
 
5’GCATGATTC gcaatcaaatataaggagttaccc3’ 
Forward primer for confirming 
HK022 cIII gene.  The EcoRI 
site is underlined. 
 
RK584 
 
5’ GCATAAGCCT gaagcatctggtgattgatgg 3’ 
Reverse primer for cloning 
HK022 cIII gene. The HindIII 
site is underlined. 
 
Table 6. Primers used for Sequencing the HK75 cI and cIII gene clones. 
RK591 5’CTCGCCTGAACATCCAATACATC3’ Sequencing primer for HK75 
pUC18 cI gene clone. 
RK592 5’ GTGATTCGTTCAAGTAAAGATTC 3’ Sequencing primer for HK75 
pUC18 cIII gene clone. 
RK118 5’ GATTATTTGCACGGCGTCACAC 3’  Sequencing primer for HK75 
pBAD18 cIII gene clones. 
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4. Preparation of plasmid DNA 
Strains carrying the pUC18 plasmid were grown in TB (50µg/ml) ampicillin at 37°C.  
The QIAprep ® kit (Cat. No. 27104)   was used for purification of plasmid DNA.  The 
bacterial cells were pelleted at 3,400 rpm for 10 minutes and resuspended in 250 µl of 
buffer P1.  To this, 250 µl of buffer P2 was added and inverted for 4-6 times.  Buffer N3 
(350 µl) was added, mixed thoroughly and the mixture was centrifuged for 10 minutes in 
a table top centrifuge at 13,000 rpm at room temperature.  The supernatant was then 
applied to a QIAprep column and centrifuged for 30 seconds.  The flow through was 
discarded. The spin column was washed with 0.5ml Buffer PB and centrifuged for 30 
seconds.   The column was then washed with 0.75ml Buffer PE and centrifuged for 30-
60s.  The flow through was discarded and the column was centrifuged for additional 1 
minute to remove residual buffer. The QIAprep column was then placed in a 1.5ml fresh 
microfuge tube.  The DNA that was bound on the resin bed was eluted with 50 µl of 
water.  The plasmid DNA was then further purified with the Millipore purification kit to 
remove excess salts. The concentration of the DNA was checked using a nanodrop 
spectrophotometer. 
5. Polymerase Chain Reaction (PCR)                                                                                                             
PCR is a technique to amplify few copies of desired DNA into millions of copies.   A 
PTC-200 Peltier thermal cycler was used for all PCR reactions. A typical program was 
run for 34 cycles with initial denaturation at 98°C for 30s, denaturation at 98 °C for 10s, 
annealing at 55°C for 30s, extension for 30s at 72°C and a final extension for 10 minutes 
at 72°C, followed by a 4 °C hold.  All reactions were carried out in PCR tubes.  The total 
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volume of each PCR reaction was 50 µl.  In whole colony PCR, the colonies to be 
screened were picked with a sterile loop and transferred into a PCR mix that has buffer, 
dNTP‟s, water, primers and Taq polymerase enzyme. 
6. Gel Electrophoresis 
One percent agarose gels (1g of agarose in 100ml 1X TAE buffer) were used to analyze 
PCR products, restriction fragments of cloned products and plasmid DNA.  The DNA 
samples were mixed with a loading dye (1X binding buffer, 20% w/v glycerol, 1mg/ml 
bromophenol blue, 1mg/ml Xylene Cyanol).  The glycerol present in the loading dye 
increases the density of the DNA during the run.  For visualization of DNA, the gels were 
stained with ethidium bromide (EtBr) for 10 minutes. 
7. Restriction digestion 
For cloning of the HK75 cI and cIII genes, two digests were performed: HindIII (NEB 
Cat.no. R0104S, 20 U/µL) and EcoRI (NEB Cat.No.R0101S, 20 U/ µL).  Restriction 
digestion of the plasmid DNA (1µg) and the insert DNA (1µg) was done with each of the 
above restriction enzymes(0.5µl) for 2 hours at 37°C.  Enzymes were then heat 
inactivated for 20 minutes at 65 °C in a heating block and purification was done between 
each digest to remove excess salts using Millipore purification kit.  The digests were then 
analyzed on 1% agarose gels. 
8. Preparation of HK022 Lysogen 
The wild type E.coli strain RK898 was grown overnight in TB media at 37°C.  The next 
day, 50 µl of bacteria was added to a tube containing 3 ml TB top agar supplemented 
with MgSO4 (final concentration 10 mM).  The tube was vortexed and the contents of the 
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tube were poured on an LB plate to make a lawn of bacterial cells.  Serial dilutions of 
HK022 phage were made in a 96 well microtiter plate in TMG buffer.  The dilutions were 
spotted onto the lawn of bacterial cells. The spots were allowed to dry and the plates were 
incubated at 37°C overnight.  Turbid spots after overnight growth indicated the presence 
of a lysogen. Potential lysogens were streaked from the turbid spots for isolation on LB 
plates. Several isolated colonies were picked, inoculated into TB and grown overnight at 
37°C.  The lysogens were confirmed by streaking them perpendicular to the phage HK75 
and looking for Immunity.  
9. Protease deficient strain 
CII protein is usually cleaved by the host HflB protease.  CIII inhibits the HflB 
proteolysis activity and protects CII from degradation by the enzyme by acting as an 
antiprotease.  A protease deficient strain was obtained from Dr. Teru Ogura (Institute of 
Molecular Embryology and Genetics, Kumamoto University) and spotting of HK75 on 
the protease deficient strain yielded lysogens.  
10. Blue-white screening 
Blue white screening is used to detect the successful insertion of DNA of interest into the 
appropriate plasmid vector.  XL-1 cells were grown until the O.D reached 0.3-0.4 and the 
vector was transformed into them.  In this screen, cells that showed successful ligation 
into the multiple cloning site produced white colonies on plates supplemented with the 
chromogenic substrate X-gal.  This was because the insertion of DNA fragment into the 
multicloning site disrupted the lacZ gene thereby preventing the production of β-
galactosidase.  In the absence of this enzyme, the substrate X-gal was not converted into 
blue colored product by the colonies and they remained white [2]. 
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11. Recombineering 
Recombineering is an efficient method of in vivo genetic engineering and is based on 
homologous recombination in E.coli mediated by lambda phage proteins [8]. It allows 
construction of DNA molecules with precise junctions. Plamid prep of the strain carrying 
the kanamycin gene was done using QIAprep 
® 
kit (Cat. No. 27104) and the cIII gene of 
HK022 was amplified with primers RK583 and RK584 and the PCR product and the 
plasmid DNA were analyzed on 1% agarose gel.  Primers (RK600 & RK601) specific for 
kanamycin gene with homology arms (50 bp) of HK022 cIII gene were designed.  The 
strain with the plasmid carrying the kanamycin gene is grown in 250 mL flask containing 
25 mL LB media supplemented with (20 µg/ml) kanamycin. When the O.D reached 0.3-
0.4, the flask is placed in the recombineering unit for shaking at 42°C to induce the 
recombinant genes for 20 minutes. The flask is then placed in ice cold water bath with 
continuous shaking for 5 minutes. The cells are then transferred to 15 mL tubes and 
centrifuged for 10 minutes at 4,400 rpm at 4°C. The supernatant is discarded and the 
pellet was washed with 3 mL 10% glycerol for 3 times. The final pellet was resuspended 
in the left over glycerol in the tube. 50 µl of the cells to be electroporated were 
transferred to a 2 mm cuvette with the cIII gene PCR product (1µl) and were pulsed at 
2.5KV, 25µF, 200 ohm with a time constant of 4.84. The cells were then suspended in 2 
mL SOC (2% tryptone, 0.5%yeast extract, 0.05% NaCl, 250mM KCl, 10mM MgSO4 and 
20 mM glucose) and incubated for 2 hours at 37°C in 15 mL tubes.  The cells are then 
extracted with 200 µl SOC and 100 µl was plated on LB (20 µg/ml) kanamycin plates 
overnight at 30°C.  The next day recombinants were picked by kanamycin resistance and 
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streaked for isolation on LB kanamycin plates. Colony PCR was performed on these 
recombinants to confirm the presence of kanamycin gene. 
12. Ligation reactions  
The ligation reactions were performed in a 10µl total reaction volume.  The reactions 
typically consisted of the following: 1.0 µl 10X T4 ligase buffer, 6:1 molar ratio of insert 
to vector (~ 50ng vector), 8.0 µl npH2O and ligase 1 µl. The reactions were incubated at 
14°C overnight. 
13. Electroporation 
The cells to be electroporated (50µl) were transferred to a 2 mm cuvette with the plasmid 
(1µl) and were pulsed at 2.5KV, 25µF, 200 ohm with a time constant of 4.84. The cells 
were then suspended in 2 ml SOC (2% tryptone, 0.5%yeast extract, 0.05% NaCl, 250mM 
KCl, 10mM MgSO4 and 20 mM glucose) and incubated for 2 hours at 37°C in 15 mL 
tubes.  The cells were then extracted with 200 µl SOC and 100 µl was plated on LB (50 
µg/ml) ampicillin plates overnight.  The next day colonies were picked and overnight 
cultures were prepared.  The cells in the overnight cultures were pelleted and stored in 
2.5 mL 10 mM MgSO4 for further confirmatory tests. 
14. Sequencing 
To confirm the HK75 cI and cIII gene pUC18 clones and HK75 pBAD18 cIII gene 
clones, plasmid from these clones was isolated using QIAprep ® kit (Cat. No. 27104) and 
analyzed on 1% agarose gels. Sequencing reactions were performed using RK 591, 
RK592 and RK118 primers. The sequencing reaction contained the following: 100 ng 
DNA, 1 μL primer, 2 μL sequencing juice 4 μL buffer (ABI Cat. no.4336917), and 
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npH2O to make a volume of 10 μL. The reactions were then placed in a thermocycler 
with the following conditions: 25 cycles of 96°C for 30s, 60°C for 30s, and 72°C for 4 
min followed by a 10°C hold. Next day, the reactions were cleaned using the Sigma-Spin 
post-reaction clean-up columns (Cat. no.S5059-70EA). The resulting samples were then 
dried down using a centrivap for 40 minutes. Samples were resuspended in 15 μL hi-di 
formamide and loaded onto an ABI3130 for analysis.
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RESULTS 
     The DNA sequence of bacteriophage HK75 shows that it is closely related to the 
temperate bacteriophage HK022 and other lambdoid phages [4] (Figure 10).  Despite this 
similarity, HK75 only forms a clear plaque which suggests it has a defect in its ability to 
form lysogens.  Previous studies on lambdoid phages have shown that a clear plaque 
phenotype can be due to a mutation in the cI, cII or cIII genes or the DNA binding sites 
for the bacteriophage CI repressor.  To identify the mutation responsible for the clear 
plaque phenotype of HK75, we first cloned HK75 cI gene into the pUC18 plasmid vector 
(Figure 11).  This was accomplished by amplifying the HK75 cI gene from purified 
HK75 DNA using primers RK578 and RK579 (See Table 4).  The resulting PCR product 
was digested individually with HindIII and EcoRI restriction enzymes.  Purified DNA 
was ligated into a pUC18 cloning vector that had also been digested with the same 
enzymes. The ligation reactions were electroporated into E. coli XL-1 cells and plated 
onto LB plates supplemented with ampicillin and X-gal.  The desired clones were then 
identified by blue white screening (Figure 12). 
     The white colonies represent the clones that carry plasmids in which the lacZ gene has 
been disrupted by the cloned DNA.  To confirm the presence of the cI gene, whole 
colony PCR was performed on selected white colonies.  Figure 13 shows the results of a 
PCR screen of whole colonies.  Clones 1-4 were positive for PCR product of the expected 
size is 729bp.  
31 
 
 
 
     No PCR product was detected in the control reaction in which a blue colony was 
tested.   These results confirm the presence of the HK75 cI gene in the pUC18 clones. 
To determine if the clones produced a functional CI repressor protein, a cross streak test 
was performed.  In a cross streak test, a sample of phage (HK75 in this case) is streaked 
down the center of an agar plate.  Bacterial cultures are then streaked perpendicular to the 
phage streak.  If the bacterial cells are sensitive to the phage infection, a difference in the 
appearance of the bacterial growth will be observed where the phage and cells come into 
contact with each other. Figure 14 shows an analysis of the recombinant plasmid DNA 
isolated from one of the HK75 cI positive clones.  The plasmid DNA was digested with 
HindIII and EcoRI and the products were analyzed by agarose gel electrophoresis.  The 
analysis shows that the vector backbone (4000bp) and a fragment corresponding to the 
cloned cI gene (729bp) are generated by this treatment.  This result confirms the integrity 
of the vector and the insert.   
     Figure 15 show the results of a cross streak assay.  The control cells (898) show 
vigorous growth up to the phage streak.  Clones1, 2 and 4 have uninterrupted growth 
across the entire plate.  This indicates that clones 1, 2 and 4 were producing functional 
repressor since the cells were resistant to infection by HK75.  The results also show that 
the operator binding sites are capable of binding repressor. This eliminates the possibility 
that the clear plaque phenotype is due to mutation in the repressor binding sites.  
The functionality of the HK75 cI gene indicates that there is no mutation in this genome 
that would explain the clear plaque phenotype of HK75. 
     Sequencing of HK75 pUC18 cI gene clones with primer RK591 (Table 6) to confirm 
the presence of the insert was also successful.
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Figure 10. Dot plot of the HK022 and HK75 genomes.  The diagonal line indicates the  
   regions of homology between the two phages [6]. 
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Figure 11. Illustration of the pUC18 Vector.  It consists of a lacZ region and an 
ampicillin resistant gene.  The lacZ bears the multiple cloning site with EcoRI and the 
HindIII sites. The yellow bar is the DNA of interest inserted between the EcoRI and the 
HindIII sites.  The pUC18 clones were selected by blue-white screening [6]. 
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Figure 12. Blue white screening of pUC18 HK75 cI gene clones on LB X-gal and 
ampicillin plates.  The white colonies represented by arrows indicate the clones that 
received the insert and the blue colonies indicate the recircularized plasmids without the 
insert. 
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Figure 13. Gel picture of the PCR product of putative HK75 cI gene clones amplified 
with the primers 578 and 580 (Table 4).  Lane (1) 1Kb ladder.  Lanes (2, 3, 4, 5) 
independent clones of  HK75 cI gene.  Lane (6) positive control (blue colour colony). 
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Figure 14. Gel picture of a restriction digestion of HK75 cI gene clone (1).  Lane (1)  
1 Kb ladder. Lane (2) Restriction digestion of a HK75 cI gene clone with EcoRI, Lane (3) 
Digestion of clone with HindIII.  Lane (4) Digestion of the cI gene clone with both 
HindIII and EcoRI that shows both vector at 4000bp and the insert of size 729bp. Lane 
(5) Uncut plasmid control. 
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Figure 15. Cross streak test of the HK75 cI gene clones. Positive control (wild type  
 E.coli). The clones along with the control were streaked perpendicular to the phage.    
The uninterrupted growth of the clones 1, 2 and 4 indicates the activity of the cI gene. 
Clone 3 on the other hand showed lysis. This could be due to no expression of the cI gene 
from this clone. 
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     A comparison of the HK75 cI, cII and cIII gene and protein sequences to the closely 
related phage HK022 revealed signifcant differences between the CIII protein (Figure 
18). Bioinformatic analysis of the HK75 and HK022 CI and CII proteins ( Figure 16 & 
17) did not show much variation in the consensus identity at the amino acid level.  
Interestingly HK75 CIII protein showed more similarity at the amino acid level with 
Lambda CIII protein(Figure 19)  which is a good example to show that phages are 
mosaic. To determine if these differences might be responsible for the clear plaque 
phenotype, we attempted to knock out the HK022 cIII gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
 
 
 
 Figure 16. Amino acid alignment of HK75 & HK022 CI proteins. The green bar     
indicates the consensus identity between the two  phages. The CI protein of both the 
phages differ by 2 amino acids.  The black asterisk indicate the termination codon where 
the translation stops[6].  
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Figure 17. Amino acid alignment of HK75 & HK022 CII proteins. The green bar 
indicates the consensus identity between the two  phages. Both the phages differ by four 
amino acid differences indicated by the gaps.  The black asterisk indicate the translation 
termination codon [6].  
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Figure 18. Amino acid alignment of HK75 & HK022 CIII proteins. The gaps in the 
consensus identity indicate the amino acid differences between these phages[6].  
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Figure 19. Amino acid alignment of HK75 & Lambda CIII proteins. The green bar 
indicates the consensus identity between the two  phages. The CIII protein of HK75 
shows more homology to Lambda CIII except for few amino acids.  The black asterisk 
indicate the termination codon [6].  
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     The main purpose of this knock out was to know whether the cIII gene of HK75 is 
defective or not.  If the knock out is successful, the HK022 cIII mutant when spotted onto 
HK022 cIII clones should form turbid plaques as there is cIII expression from the clones. 
On the other hand, spotting of HK022 cIII
 
mutant on  HK75 cIII clones should form clear 
plaques if the phage carries a mutation in the cIII gene that renders the protein inactive. 
We first attempted to knockout the cIII gene of HK022 by replacing it with a  kanamycin 
resistance gene.  Recombinants were selected on LB supplemented with kanamycin.  The 
cIII gene and the kanamycin gene were amplified with primers RK583, RK584 and 
RK600 and RK601 ( Table 5) separately by PCR.  The PCR product was analyzed on an 
agarose gel.  The gel picture showed both the kanamycin and cIII gene products (Figure 
20) indicating that though the recombineering was successful, it could not replace the 
HK022 cIII gene and might have got incorporated somewhere else in the phage genome. 
Since we did not successfully knockout the HK75 cIII  gene,  we decided to  clone the 
HK75 cIII gene into a pUC18 cloning vector.  Similar to the  HK75 cI gene cloning,  
HK75 cIII clones were identified by blue white screening.  To test the expression of cIII 
gene from these clones, cultures  were prepared and bacterial lawns on LB plates were 
prepared.  Serial dilutions of HK75 phage were then spotted onto the lawns.  XL-1  was 
used as a control.  In all cases, clear plaques were obtained.  This result indicates  that 
there is no expression of  the cIII gene from the clones or the CIII protein is defective 
(Figure 21). 
     Sequencing to confirm the HK75 pUC18 cIII gene clones with primer RK592 (Table 
6) was successful indicating the presence of  the insert in the clones.  
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     As there was no expression of cIII gene from the pUC18 clones, we then cloned the 
HK75 cIII gene into an expression vector pBAD18 (Figure 22).   The main purpose of 
this cloning is that pBAD vector expression can be controlled in the presence or absence 
of arabinose.  Clear plaques were obtained in the absence of arabinose when the cIII gene 
is not expressed whereas turbid plaques were obtained in the presence of arabinose.  The 
presence of turbid plaques may be due to overexpression of  the cIII  gene from these 
clones.  Cells from the turbid spots were streaked for isolation on LB plates.  Cultures of 
these potential lysogens were then prepared to confirm the presence of prophage using 
PCR with primers that amplify the HK75 cI gene. 
     The PCR product showed  expected product size of 729 bp confirming the presence of 
lysogens (Figure 23).  The lysogen formation could be due to  the overexpression of cIII 
gene from pBAD18 clones.  When cIII gene is overexpressed, it acts as a target for host 
proteases.  As a result, CII is stabilized and promotes the establishment of lysogeny. 
Sequencing to confirm the  HK75 pBAD18 cIII gene clones with primer RK118 (Table 
6) failed. 
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Figure 20. Colony PCR of HK022 cIII gene recombinants.  Lane (1) 1 kb ladder, Lanes 
(2,3,4,5) independent recombinants amplified with kanamycin primers,600X601.  
Lane(6)  negative control.  Lane (7) 100bp ladder.  Lanes (8,9) independent recombinants 
amplified with cIII gene primers.  
The expected product size of the kanamycin resistance gene is 1039bp and that of the cIII 
gene is 283bp. 
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Figure 21. Immunity test of the HK75 on HK75 cIII gene clones (left) and XL-1(right).  
Dilutions (10
-1
 to 10
-16  
)  were made and spotted on XL-1 and (10
-1
 to 10
-12 
)
  
 on to the 
lawns of HK75 cIII clones from right to left.  XL-1 should form clear plaques whereas 
the  cIII clones if expressing should form turbid plaques if the CIII protein is produced.  
In both cases, only clear plaques were observed. This indicates that either there is a 
deleterious mutation in the cIII gene or there is no expression from the clones. 
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Figure 22. Illustration of the pBAD18, an expression vector with ampicillin resistance 
gene, pBAD18 promoter and arabinose gene[6]. The pBAD promoter is usually repressed 
and can be induced in the presence of the inducer, arabinose. The EcoRI and the HindIII 
sites are the sites used for the insertion of DNA of interest during cloning 
 
 
 
 
                                                  
48 
 
 
 
                                                  1               2              3                4 
 
 
 Figure 23. Gel picture showing the PCR products of the potential lysogens with primers 
that amplify the cI gene of HK75.  Lane (1) 1 Kb ladder.  Lanes ( 2,3,4) independent 
lysogens of pBAD18 cIII gene clones. Two of the three lysogens yielded the expected 
product size of 729bp. 
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     During lysogeny, protein CIII allows the stabilization of the CII protein, a 
transcriptional activator.  CII is very unstable and is usually degraded by host proteases. 
The function of the cIII gene product is to prevent the proteolytic degradation of the 
phage CII protein by acting as an antiprotease.  Stabilization can be achieved by 
overepressing a protein target of the protease or by inactivating the protease itself. 
     We obtained a protease deficient strain from Dr.Teru Ogura (Institute of Molecular 
Embryology and Genetics, Kumamoto University) and asked if HK75 could successfully 
lysogenize this strain.  Dilutions of HK75 phage were spotted on the protease deficient 
strain and on a  wild type strain as a control. After overnight incubation at 30°C, the spots 
appeared turbid on the protease deficient strain and clear on the wild type control (Figure 
24).   Lysogenic cells were purified by streaking cells from the dilution spot (10
-9
) onto 
the LB plates.  Lysogens were recovered and confirmed by colony PCR with the primers 
578 and 580 that amplify the HK75 cI gene ( Figure 26).  
     To further confirm these lysogens, another assay was performed to look for exclusion 
mechanism. In this assay, the lysogens were streaked against wild type λ phage and 
checked for nun exclusion (Figure 25).  Lysogens of  HK022 and HK75 express a protein 
called Nun.  The Nun protein bind to the nut sites of the Lambda phage DNA thereby 
preventing Lambda growth.  
     These results show that CII needs to be stabilized for its function. When it is 
stabilized, lysogens can be recovered.  The concentration of CII plays a critical role in the 
lysis-lysogeny decision.  High concentration of CII favors lysogeny.  
     All the above results eliminate the possibility that the clear plaque phenotype is due to 
a mutation in the cII gene.  
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Figure 24. Spot dilutions of HK75 on a protease deficient strain of E.coli [ Table 1] . 
Turbid spots indicate the presence of the lysogenic cells. Clear plaques were obtained 
when phage dilutions were spotted on XL-1 as a control (data not shown). 
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Figure 25. Lambda exclusion test.  Cross streak test of HK75 lysogens of the protease 
deficient strain against wild type Lambda phage with wild type E.coli (RK 898) as 
positive control was performed.  The lysogens were resistant to the lambda phage and 
prevented its growth by expressing the protein Nun. Nun binds to the phage nut sites 
thereby blocking the growth of Lambda. The positive control showed lysis once it 
touched the phage streak. 
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Figure 26. Gel picture of colony PCR of putative HK75 lysogens of protease deficient 
strain. Lane (1) 1 kb ladder, Lanes (2,3) DNA purified from two independent HK75 
lysogens amplified with Primers 578 and 580 which are specific for HK75 cI gene. Lane 
(4) negative control. The expected PCR product size is 729 bp.
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DISCUSSION 
     Temperate bacteriophage can adopt two different lifestyles upon infection of a suitable 
host.  Bacteriophage HK022 is a temperate phage that has a unique RNA based 
mechanism for promoting transcription antitermination.  Antitermination allows the 
expression of genes located downstream of transcription terminators and this activity is 
necessary for the phage to complete the lytic cycle.  The host RNA polymerase interacts 
directly with the phage encoded antiterminator RNAs and this interaction converts the 
polymerase into a termination resistant form.  Specific mutations in the host RNA 
polymerase (i.e. rpoCY75N) prevent the interaction and consequently block phage 
growth.  Bacteriophage HK75 has a similar genetic organization as HK022 and these two 
phages are homoimmune.  HK75 was discovered by its inability to grow on the 
rpoCY75N mutant; this and other evidence shows that HK75, like HK022, uses 
antiterminator RNA molecules to promote full gene expression.  However, there is a 
striking phenotypic difference between HK022 and HK75; HK022 can form lysogens 
whereas HK75 cannot.  We were interested in determining the underlying cause of this 
difference.  Previous studies on the prototypical temperate phage, phage Lambda, showed 
that a clear plaque phenotype is commonly caused by a mutation in one of the three 
genes; cI, cII or cIII.   Bioinformatic analysis of the HK75 and HK022 CI, CII and CIII 
proteins revealed that HK75 CI and CII proteins had minor differences in their amino 
acid sequences when compared to the corresponding HK022 proteins (Figures 16, 17).   
However, the HK75 and HK022 CIII proteins had major differences in their amino acid 
sequences (Figure 18).  We hypothesized that these differences may be responsible for 
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the clear plaque phenotype of phage HK75.  Previous studies have shown that the activity 
of the CIII protein lies in the 22 amino terminal amino acid residues [18]. 
     Although the HK75 CI protein is nearly identical to the HK022 CI protein, we could 
not rule out the possibility that the minor differences were actually responsible for the 
clear plaque phenotype.  Therefore, we cloned the HK75 cI gene to determine if it could 
produce a functional repressor.  The pUC18 cloning vector was used because the clones 
could be identified easily by blue-white screening. The presence of the insert in the 
clones was confirmed by restriction digestion and whole colony PCR.  The expression of 
the cI gene from the clones was assayed by a cross streak test in which an LB plate was 
seeded with a single streak of the HK75 phage down the center of the plate.  Cell 
suspensions of the HK75 cI gene clones were streaked perpendicular to the phage streak.  
The control cells showed lysis where the cells encountered the phage whereas the cI gene 
clones showed uninterrupted growth even after touching the phage streak ( Figure 15 ).  
These results confirmed that the HK75 cI gene is functional because the expression of the 
gene produced a repressor protein that efficiently prevented HK75 growth; this repressor 
mediated phenomenon is known as immunity.   
     To determine if the clear plaque phenotype was due to the observed differences in the 
HK75 CIII protein, we cloned the HK75 cIII gene into the puc18 cloning vector.  The 
clones were identified by blue-white screening as described above. Cultures of the cIII 
gene clones were prepared and gene activity was assayed by spotting serial dilutions of 
the HK75 phage onto bacterial lawns prepared from the candidate clones.  In this case, 
gene activity was determined by looking for turbid spots which are indicative of 
lysogenization.  Only clear plaques were observed.  These results suggested that the cIII 
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gene was nonfunctional or alternatively, the gene was simply not expressed from these 
clones.  To address the possible lack of cIII gene expression, we cloned the HK75 cIII 
gene into a pBAD18 expression vector.  The purpose of using this particular vector is that 
its expression can be controlled by adding or withholding arabinose, the inducer of the 
pBAD promoter.  In these experiments, lysogens were only recovered in the presence of 
arabinose.  This suggests that the over expression of the cIII gene is necessary to promote 
lysogeny.   
     The protein alignment of the CII protein of HK75 and HK022 showed only minor 
differences at the amino acid level. The CII protein acts as a transcriptional activator of 
the cI gene and the integrase gene.  The products of these genes are required for the 
establishment of lysogeny.  The CII protein is usually degraded by the host protease 
HflB/FtsH.  During the establishment of lysogeny, the CIII protein acts as an antiprotease 
and protects CII from degradation.  We obtained a protease deficient strain from Dr. Teru 
Ogura (Institute of Molecular Embryology and Genetics, Kumamoto University) to test 
whether HK75 can produce a functional CII protein.  Serial dilutions of phage HK75 
were made and spotted on lawns of this strain and turbid plaques were obtained after cell 
growth.  PCR was performed with primers that amplify the cI gene of HK75 to confirm 
the presence of the prophage.  We obtained the expected product size of the PCR (729 
bp) from the putative lysogens.  This result confirmed the presence of the prophage. 
Additional confirmation was achieved by performing a cross streak test.  In this case, we 
looked for phage exclusion by seeding a plate with a single streak of phage Lambda.  The 
putative lysogens were then streaked perpendicular to the Lambda phage streak.  
Uninterrupted growth of the lysogens that were streaked across the plate is due to the 
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production of the phage NUN protein.  This protein has been shown to prevent 
superinfection of HK022 lysogens by phage Lambda.  All of the putative HK75 lysogens 
excluded Lambda.  This result confirmed the presence of the prophage and demonstrated 
the activity of the NUN protein.  The recovery of lysogens from the protease deficient 
strain indicates that the CII protein is active; lysogens would only be formed if the CII 
protein was stabilized and successfully activated transcription.  These results suggest that 
the observed differences in the amino acid sequences of the HK75 and HK022 CII 
proteins are not responsible for the clear plaque phenotype of HK75.    
     We have used genetics, molecular techniques and in vivo assays to determine why 
bacteriophage HK75 displays a clear plaque phenotype. Our results indicate that the clear 
plaque phenotype of HK75 is due to a defect in cIII gene expression and/or the stability 
of the CIII protein.  Future work may include the use of qPCR to determine if the cIII 
gene is expressed in the phage.  In addition, an immunoblot may be used to determine the 
presence and the levels of the CIII protein.  The immunoblot experiements would be very 
informative but require the production HK75 CIII specific antibodies.  The discovery of 
how to make HK75 lysogens will allow further characterization of its RNA based 
mechanism of transcription antitermination.  HK75 is only the second phage that has 
been shown to use this unusual mechanism of transcription control.
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